Navigation Links
PRP treatment aids healing of elbow injuries say researchers
Date:2/11/2012

SAN FRANCISCO, CA As elbow injuries continue to rise, especially in pitchers, procedures to help treat and get players back in the game quickly have been difficult to come by. However, a newer treatment called platelet rich plasma (PRP) may pose hope, according to researchers presenting their findings at the American Orthopaedic Society for Sports Medicine's Specialty Day meeting in San Francisco.

"PRP therapy is a very exciting area of research and a number of questions still need to be answered, including optimal concentration, number and timing of injections, the role of white blood cells and the role of ultrasound or image guidance when performing these injections," said lead researcher, Scott A. Crow, MD of the Kerlan-Jobe Orthopaedic Clinic in Los Angeles, California. "Despite these questions, this study indicates that in the short term, PRP may be an effective option to successfully treat partial ulnar collateral ligament (UCL) tears in the elbow of athletes."

The researchers followed 17 athletes with a partial UCL tear. All patients had failed conservative treatment, including rest and physical therapy. Baseline questionnaires, including the Kerlan-Jobe Shoulder and Elbow Score (KJOC Score) and Disability of the Arm, Shoulder, and Hand Score (DASH Score) were completed for each patient prior to the PRP injection. Each patient underwent a single PRP injection at the ulnar collateral ligament under ultrasound guidance.

At an average follow-up of 18 weeks (range 12-46 weeks), 16 of 17 athletes had returned to play. The average time to return to play was 10 weeks (range 8-12 weeks). The average KJOC Score improved from 47 to 93, p=.0001. The average DASH Score improved from 24 to 3, p=.003. The Sports Module of the DASH questionnaire improved from 74 to 6, p=.0001.

"There is little information in the literature regarding non-surgical treatment of UCL tears. Our results show that PRP may be an option to return player
'/>"/>

Contact: Lisa Weisenberger
lisa@aossm.org
847-29Select individ-4900
American Orthopaedic Society for Sports Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Treatment for hip conditions should not rest solely on MRI scans
2. New data provides direction for ACL injured knee treatments
3. Steroid injections prove effective in treatment of lumbar disc herniations
4. HIV Severity, Treatment Unrelated to Kids Mental Woes: Study
5. Y-90: Are you ready? -- comprehensive liver tumor treatment course returns
6. Donation opens new opportunities for more effective diabetes treatment
7. New technology to tackle treatment-resistant cancers
8. Type 1 Diabetes Treatment Disappoints in Trial
9. Exercise a Good Pick-Me-Up After Cancer Treatment: Study
10. Study Compares 3 Common Prostate Cancer Treatments
11. Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... (HealthDay News) -- New research suggests that young asthma ... such as ipratropium [Atrovent] -- could be more likely ... However, the increased risk was not seen ... raises concern because of the recent interest in use ... the University of Illinois at Chicago, said in a ...
(Date:5/23/2012)... Prior treatment with inhaled corticosteroids in patients ... (CAP) is associated with a lower incidence and ... study from researchers in Spain. , A parapneumonic ... fluid that accumulates between the two pleural layers, ... arises as a result of a pneumonia, lung ...
(Date:5/22/2012)... OAK BROOK, Ill. Magnetic resonance imaging (MRI) ... to pre-surgical chemotherapy significantly earlier than possible through ... online in the journal Radiology . ... prior to surgery. Research has shown that women ... are more likely to achieve breast conservation than ...
(Date:5/22/2012)... By Carina Storrs HealthDay Reporter , , TUESDAY, ... treating obstructive sleep apnea, a common cause of snoring ... serious health hazard associated with the condition -- the ... Spain examined the number of new cases of high ... used continuous positive airway pressure therapy, or CPAP, for ...
(Date:5/22/2012)... Researchers at Barrow Neurological Institute at St. Joseph,s ... why the public perceives some magic tricks in ... military tactics, marketing and sports. , Susana Martinez-Conde, ... Stephen Macknik, PhD, of Barrow,s Laboratory of Behavioral ... magic and illusions. Their most recent original research ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Barrow researchers use magic for discoveries 2
... levels of certain cytokines spiked during disease stage , , ... Africa recently had the rare opportunity to follow the ... recovery in a 29-year-old lab worker who had accidentally ... the researchers followed the trajectory of cytokines, a type ...
... ATLANTA Georgia State University and the Georgia Institute ... provide researchers around Atlanta with a dedicated magnetic resonance ... the brain and mind. , The Center for Advanced ... Georgia Tech, opened this month for researchers exploring topics ...
... disease recurrence, death nearly twice that of normal-weight patients ... cancer patients are more likely than non-obese patients to ... say U.S. researchers. , "We identified a subset ... at 12-fold increased risk of lymph node metastasis compared ...
... until Executive Search for Replacement is CompletedPlanned Investor ... at 4:15 PM ET LIVINGSTON, N.J., March ... MLSS), the recognized leader in advanced injection technologies, ... Board, will temporarily assume the post of Interim ...
... The American Academy of Nurse Practitioners (AANP) announces the ... AANP Chief Executive Officer, effective March 20, 2009. ... will retire after 13 years as CEO of AANP. ... in her role as Executive Director of the AANP ...
... Event held in partnership with Children,s Hospital of Michigan ... for vehicle travelProper use of booster seats and car ... road , DETROIT, March 18 Parents and caregivers ... children for vehicle travel during the Second Annual ...
Other Medicine News:Health News:Course of West Nile Infection Charted 2Health News:Course of West Nile Infection Charted 3Health News:Georgia State/Georgia Tech Center for Advanced Brain Imaging to expand brain, mind research 2Health News:Obesity Tied to Poor Pancreatic Cancer Surgery Outcomes 2Health News:Milestone Scientific Announces Resignation of CEO 2Health News:Milestone Scientific Announces Resignation of CEO 3Health News:American Academy of Nurse Practitioners Announces New Chief Executive Officer 2Health News:Wayne County Community College District Presents Second Annual Child Car Seat Check Program 2
(Date:5/23/2012)... -- According to Cold Chain IQ ... excursions in 6% or more of their temperature ... can not only result in product losses, but ... IQ presents a new report examining temperature excursions ... products and leading strategies that the pharmaceutical industry ...
(Date:5/22/2012)... SmallCapVoice.com, Inc. announced today that ... Inc. (PINKSHEETS: MJNA) is now available. The ... . Recent company activity and ... income of approximately $1.21 million on gross ... ended March 31, 2012.  This represents a ...
(Date:5/22/2012)... -- Prime Therapeutics (Prime), a leading pharmacy benefit manager, ... chief financial officer (CFO). DuCharme will lead Prime,s finance ... growth. "Jim brings deep health plan expertise ... within diverse health plans, including Blue Cross and Blue ... Prime. "Based on his strong belief in pharmacy as ...
Breaking Medicine Technology:New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 3Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 1Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 2Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 3Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 5Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 6Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 7Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 1Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 2Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 3Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 4Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 5Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 6Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 7Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 1Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 2Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 3
... Efficacy Results Support Follow-on NEST-3 TrialCARLSBAD, Calif., Feb. ... PhotoThera, Inc., transcranial laser therapy (TLT) for acute ... demonstrated improved outcomes for patients, but did not ... analysis in patients who had moderate to moderately ...
... Bulletin Board: GOVX), an Atlanta-based, publicly traded,biopharmaceutical company ... Immunodeficiency Virus) and other infectious agents, announced,the first ... Trial for its,candidate HIV/AIDS vaccine. The trial, ... Vaccine Trials Network (HVTN). The HVTN, funded ...
Other Medicine Technology:Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009 2GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 2GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 3GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 4GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 5
... onlays are pre-cut and pre-shaped to facilitate ... more frequently done. These pre-shaped onlays are ... Ultra and are designed for use in ... both small and large sizes, they provide ...
... and soft tissue reconstructions, and in ... is sometimes necessary to encourage host ... minimizing tissue attachment along another surface.,GORE ... ePTFE sheet material that offers a ...
... is pleased to announce the latest advancement ... E/X mesh.,When Bard Composix mesh was introduced ... hernia repair prosthesis that combined two clinically ... in one product. Bard Composix E/X mesh, ...
... introduction in 1958, Bard mesh has become ... are compared. Bard mesh was used by ... the "tension-free" hernia repair many years ago. ... and ideal" substance for permanent reinforcement of ...
Medicine Products: